ICER Publishes Final Evidence Report, Policy Recommendations on Beti-Cel Gene Therapy for Beta Thalassemia
July 22, 2022
July 22, 2022
BOSTON, Massachusetts, July 22 (TNSres) -- The Institute for Clinical and Economic Review issued the following news release on July 19, 2022:
* * *
Independent appraisal committee unanimously determined that evidence is adequate to demonstrate that beti-cel provides a net health benefit compared to standard clinical management
Given the high costs of standard care, cost-effectiveness modeling finds beti-cel meets commonly accepted value thresholds at an an . . .
* * *
Independent appraisal committee unanimously determined that evidence is adequate to demonstrate that beti-cel provides a net health benefit compared to standard clinical management
Given the high costs of standard care, cost-effectiveness modeling finds beti-cel meets commonly accepted value thresholds at an an . . .